2026 Drug Development Outlook: What Industry Insiders Are Saying
February 4, 2026
In this new interview, veteran pharma journalist Cindy H. Dubin reveals the real shifts leaders are betting on for 2026:
AI completely changing how drugs are discovered and developed
Cell & gene therapies expanding far beyond rare diseases
Serious (and profitable) moves toward sustainable packaging
FDA pathways rewarding digital-ready, transparent companies
Want the full picture — including major company examples and hard numbers? Watch the conversation.
